FDA approves test to detect DNA of cancer-causing HPV strains
(Reuters) - The Food and Drug Administration on Thursday approved the use of a test for cancer-causing strains of the human papillomavirus (HPV), clearing the way for replacement of the Pap smears used to screen most women for cervical cancer.
The FDA said the cobas HPV Test, made by Switzerland's Roche Holding AG, can be used for women age 25 and older to help assess the need for additional diagnostic testing.
The test had previously been approved in conjunction with, or as a follow up to, a Pap test, which examines cervical cells for changes that might become cervical cancer.
Experts have said it will be tough to convince doctors to move from the current testing guidelines, which call for the use of both Pap tests and HPV tests, since there have been no studies directly comparing the regimens.
(Reporting By Deena Beasley; Editing by Nick Zieminski)
- Israel pummels Gaza; Kerry steps up diplomatic push |
- With sales sputtering, Apple's iPad looks to IBM alliance
- Ukraine war crimes trials a step closer after Red Cross assessment
- Five held in China food scandal probe, including head of Shanghai Husi Food
- Rebels likely downed Malaysian jet 'by mistake': U.S. officials
Robert Blendon of the Harvard School of Public Health says the Affordable Care Act's unpopularity in 12 key states will keep it a central issue in the 2014 elections. Video